Guro Berge

473 total citations
15 papers, 341 citations indexed

About

Guro Berge is a scholar working on Physiology, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Guro Berge has authored 15 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 9 papers in Psychiatry and Mental health and 4 papers in Neurology. Recurrent topics in Guro Berge's work include Alzheimer's disease research and treatments (9 papers), Dementia and Cognitive Impairment Research (9 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Guro Berge is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Dementia and Cognitive Impairment Research (9 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Guro Berge collaborates with scholars based in Norway, Sweden and United States. Guro Berge's co-authors include Linda R. White, Sigrid Botne Sando, Geir Bråthen, Gøril Rolfseng Grøntvedt, Arvid Rongve, Dag Aarsland, Måns Åkerman, H Rorsman, Øyvind Salvesen and Kalicharan Patra and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, British Journal of Dermatology and Journal of Alzheimer s Disease.

In The Last Decade

Guro Berge

14 papers receiving 328 citations

Peers

Guro Berge

PHYSI

PMH

NEURO

Shanti Mehta Canada

Stavra N. Romas United States

M M Esiri United Kingdom

Isabel Lamet Spain

Felecia M. Marottoli United States

D. Lefranc France

Laura de Diego-García Spain

Carolin Heller United Kingdom

Matthias Ebbinghaus Germany

Dustin Chernick United States

Shanti Mehta Canada

Guro Berge

194 ×0.9

PHYSI

90 ×0.8

PMH

86 ×1.2

36 ×0.5

NEURO

42 ×0.6

NEURO

Citations per year, relative to Guro Berge Guro Berge (= 1×) peers Shanti Mehta

Countries citing papers authored by Guro Berge

Since Specialization

Citations

This map shows the geographic impact of Guro Berge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guro Berge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guro Berge more than expected).

Fields of papers citing papers by Guro Berge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guro Berge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guro Berge. The network helps show where Guro Berge may publish in the future.

Co-authorship network of co-authors of Guro Berge

This figure shows the co-authorship network connecting the top 25 collaborators of Guro Berge. A scholar is included among the top collaborators of Guro Berge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guro Berge. Guro Berge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Carlsson, Henrik, Kalicharan Patra, Sigrid Botne Sando, et al.. (2022). Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer’s disease. Alzheimer s Research & Therapy. 14(1). 115–115. 24 indexed citations

Grøntvedt, Gøril Rolfseng, Guro Berge, Linda R. White, et al.. (2020). The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up. Journal of Alzheimer s Disease. 74(3). 829–837. 31 indexed citations

Patra, Kalicharan, Anna Edlund, Sigrid Botne Sando, et al.. (2019). Plasma Apolipoprotein E Monomer and Dimer Profile and Relevance to Alzheimer’s Disease. Journal of Alzheimer s Disease. 71(4). 1217–1231. 15 indexed citations

Rodriguez‐Vieitez, Elena, Sigrid Botne Sando, Guro Berge, et al.. (2018). The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease. Acta Neuropathologica Communications. 6(1). 130–130. 56 indexed citations

Patra, Kalicharan, Antoninus Soosaipillai, Sigrid Botne Sando, et al.. (2018). Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer’s disease. Alzheimer s Research & Therapy. 10(1). 9–9. 27 indexed citations

Sando, Sigrid Botne, Guro Berge, Gøril Rolfseng Grøntvedt, et al.. (2017). Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer’s Disease, But Has Similar Diagnostic Accuracy to Aβ42. Frontiers in Aging Neuroscience. 9. 210–210. 22 indexed citations

Berge, Guro, Sigrid Botne Sando, Grethe Albrektsen, et al.. (2016). Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study. BMC Neurology. 16(1). 180–180. 23 indexed citations

Sando, Sigrid Botne, Guro Berge, Gøril Rolfseng Grøntvedt, et al.. (2016). Cerebrospinal Fluid Levels of Amyloid Beta 1–43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer’s Disease: A 2-Year Follow-Up Study. Frontiers in Aging Neuroscience. 8. 30–30. 10 indexed citations

Vijayaraghavan, Swetha, Taher Darreh‐Shori, Arvid Rongve, et al.. (2016). Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer’s Disease. Journal of Alzheimer s Disease. 50(2). 567–576. 16 indexed citations

10.

Berge, Guro, Sigrid Botne Sando, Daniel Holder, et al.. (2015). Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer’s Disease, Mild Cognitive Impairment, or Healthy Control Individuals. Journal of Alzheimer s Disease. 49(2). 493–502. 10 indexed citations

11.

Berge, Guro, Sigrid Botne Sando, Arvid Rongve, Dag Aarsland, & Linda R. White. (2014). Apolipoprotein E 2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort. Journal of Neurology Neurosurgery & Psychiatry. 85(11). 1227–1231. 57 indexed citations

12.

Sando, Sigrid Botne, Guro Berge, Jan Aasly, et al.. (2012). P3‐095: Changes in core biomarkers in cerebrospinal fluid and cognitive ability in patients with Alzheimer's disease: A two‐year longitudinal study. Alzheimer s & Dementia. 8(4S_Part_13). 1 indexed citations

13.

Vaa, Truls, et al.. (2002). Faktorer som påvirker kjørefart Litteraturstudier og hypoteser SIP Føreratferdsmodeller: Rapport 2. 1 indexed citations

14.

Erpecum, Karel J. van & Guro Berge. (1989). Pathogenetic Factors in Cholesterol Gallstone Disease. Scandinavian Journal of Gastroenterology. 24(sup171). 83–90. 6 indexed citations

15.

Berge, Guro, et al.. (1970). LIVER BIOPSY IN PSORIASIS. British Journal of Dermatology. 82(3). 250–253. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact